<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34210789</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1399-3003</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The European respiratory journal</Title><ISOAbbreviation>Eur Respir J</ISOAbbreviation></Journal><ArticleTitle>Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2101341</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1183/13993003.01341-2021</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The long-term sequelae of coronavirus disease 2019 (COVID-19) in children remain poorly characterised. This study aimed to assess long-term outcomes in children previously hospitalised with COVID-19 and associated risk factors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a prospective cohort study of children (&#x2264;18&#x2005;years old) admitted to hospital with confirmed COVID-19. Children admitted between 2 April 2020 and 26 August 2020 were included. Telephone interviews used the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) COVID-19 Health and Wellbeing Follow-up Survey for Children. Persistent symptoms (&gt;5&#x2005;months) were further categorised by system(s) involved.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">518 out of 853 (61%) eligible children were available for the follow-up assessment and included in the study. Median (interquartile range (IQR)) age was 10.4 (3-15.2)&#x2005;years and 270 (52.1%) were girls. Median (IQR) follow-up since hospital discharge was 256 (223-271)&#x2005;days. At the time of the follow-up interview 126 (24.3%) participants reported persistent symptoms, among which fatigue (53, 10.7%), sleep disturbance (36, 6.9%) and sensory problems (29, 5.6%) were the most common. Multiple symptoms were experienced by 44 (8.4%) participants. Risk factors for persistent symptoms were: older age "6-11&#x2005;years" (OR 2.74, 95% CI 1.37-5.75) and "12-18&#x2005;years" (OR 2.68, 95% CI 1.41-5.4), and a history of allergic diseases (OR 1.67, 95% CI 1.04-2.67).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A quarter of children experienced persistent symptoms months after hospitalisation with acute COVID-19 infection, with almost one in 10 experiencing multisystem involvement. Older age and allergic diseases were associated with higher risk of persistent symptoms at follow-up.</AbstractText><CopyrightInformation>Copyright &#xa9;The authors 2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Osmanov</LastName><ForeName>Ismail M</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Z.A. Bashlyaeva Children's Municipal Clinical Hospital, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pirogov Russian National Research Medical University, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>These authors contributed equally to this article.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spiridonova</LastName><ForeName>Ekaterina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Dept of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>These authors contributed equally to this article.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bobkova</LastName><ForeName>Polina</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Dept of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>These authors contributed equally to this article.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gamirova</LastName><ForeName>Aysylu</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dept of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>These authors contributed equally to this article.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shikhaleva</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dept of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>These authors contributed equally to this article.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreeva</LastName><ForeName>Margarita</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dept of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>These authors contributed equally to this article.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blyuss</LastName><ForeName>Oleg</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Dept of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Physics, Astronomy and Mathematics, University of Hertfordshire, Hatfield, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>These authors contributed equally to this article.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Taravi</LastName><ForeName>Yasmin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Dept of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DunnGalvin</LastName><ForeName>Audrey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dept of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Applied Psychology, University College Cork, Cork City, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Comberiati</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Dept of Clinical and Experimental Medicine, Section of Pediatrics, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peroni</LastName><ForeName>Diego G</ForeName><Initials>DG</Initials><Identifier Source="ORCID">0000-0002-0234-1373</Identifier><AffiliationInfo><Affiliation>Dept of Clinical and Experimental Medicine, Section of Pediatrics, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apfelbacher</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Social Medicine and Health Systems Research, Faculty of Medicine, Otto von Guericke University Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Genuneit</LastName><ForeName>Jon</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5764-1528</Identifier><AffiliationInfo><Affiliation>Pediatric Epidemiology, Dept of Pediatrics, Medical Faculty, Leipzig University, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazankova</LastName><ForeName>Lyudmila</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-0895-6707</Identifier><AffiliationInfo><Affiliation>Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miroshina</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Z.A. Bashlyaeva Children's Municipal Clinical Hospital, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chistyakova</LastName><ForeName>Evgeniya</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Dept of Paediatrics and Paediatric Rheumatology, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samitova</LastName><ForeName>Elmira</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Z.A. Bashlyaeva Children's Municipal Clinical Hospital, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borzakova</LastName><ForeName>Svetlana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pirogov Russian National Research Medical University, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Dept, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bondarenko</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Dept of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korsunskiy</LastName><ForeName>Anatoliy A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Dept of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konova</LastName><ForeName>Irina</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-1070-9059</Identifier><AffiliationInfo><Affiliation>Z.A. Bashlyaeva Children's Municipal Clinical Hospital, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanson</LastName><ForeName>Sarah Wulf</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carson</LastName><ForeName>Gail</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>ISARIC Global Support Centre, Nuffield Dept of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigfrid</LastName><ForeName>Louise</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-2764-1177</Identifier><AffiliationInfo><Affiliation>ISARIC Global Support Centre, Nuffield Dept of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Janet T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenhawt</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dept of Pediatrics, Section of Allergy/Immunology, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whittaker</LastName><ForeName>Elizabeth A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Paediatric Infectious Diseases, Imperial College Healthcare NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garralda</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Psychiatry, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swann</LastName><ForeName>Olivia V</ForeName><Initials>OV</Initials><AffiliationInfo><Affiliation>Dept of Child Life and Health, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paediatric Infectious Diseases, Royal Hospital for Children, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buonsenso</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8567-2639</Identifier><AffiliationInfo><Affiliation>Dept of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Global Health Research and Studies, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicholls</LastName><ForeName>Dasha E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Division of Psychiatry, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simpson</LastName><ForeName>Frances</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Coventry University, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Christina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3672-6631</Identifier><AffiliationInfo><Affiliation>School of Psychology, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semple</LastName><ForeName>Malcolm G</ForeName><Initials>MG</Initials><Identifier Source="ORCID">0000-0001-9700-0418</Identifier><AffiliationInfo><Affiliation>Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dept of Respiratory Medicine, Alder Hey Children's Hospital, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warner</LastName><ForeName>John O</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>Inflammation, Repair and Development Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vos</LastName><ForeName>Theo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olliaro</LastName><ForeName>Piero</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>ISARIC Global Support Centre, Nuffield Dept of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munblit</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9652-6856</Identifier><AffiliationInfo><Affiliation>Dept of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia daniel.munblit08@imperial.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inflammation, Repair and Development Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research and Clinical Center for Neuropsychiatry, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>These authors contributed equally to this article.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>and the Sechenov StopCOVID Research Team</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_PC_15001</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_19026</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_19059</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_UU_12014/8</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Respir J</MedlineTA><NlmUniqueID>8803460</NlmUniqueID><ISSNLinking>0903-1936</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur Respir J. 2022 Feb 3;59(2):2102245. doi: 10.1183/13993003.02245-2021</RefSource><PMID Version="1">34531277</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002673" MajorTopicYN="N">Child, Hospitalized</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Conflict of interest: J. Genuneit reports working as a project manager of unrestricted research grants on the composition of breast milk to Ulm University and Leipzig University with funding from Danone Nutricia Research. M.G. Semple reports grants from the Dept of Health and Social Care National Institute of Health Research UK, grants from the Medical Research Council UK, grants from the Health Protection Research Unit in Emerging &amp; Zoonotic Infections, University of Liverpool, outside the submitted work; he also reports a minority ownership at Integrum Scientific LLC (Greensboro, NC, USA), outside the submitted work. T. Vos reports personal fees for work on the Global Burden of Disease Study from the Bill and Melinda Gates Foundation, outside the submitted work. C. Apfelbacher has received lecture fees from AstraZeneca, and is a member of a group developing a core outcome set for long COVID, outside the submitted work. All other authors report no relevant conflict of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>2</Day><Hour>5</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34210789</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pii">13993003.01341-2021</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C, Huang L, Wang Y, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021; 397: 220&#x2013;232. doi:10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Bobkova P, Spiridonova E, et al. . 
Risk factors for long-term consequences of COVID-19 in hospitalised adults in Moscow using the ISARIC Global follow-up protocol: StopCOVID cohort study. medRxiv
2021; preprint [10.1101/2021.02.17.21251895]. doi:2021.2002.2017.21251895</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.17.21251895</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. Long Covid: WHO calls on countries to offer patients more rehabilitation. BMJ 2021; 372: n405. doi:10.1136/bmj.n405</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n405</ArticleId><ArticleId IdType="pubmed">33568362</ArticleId></ArticleIdList></Reference><Reference><Citation>Editorial . Meeting the challenge of long COVID. Nat Med 2020; 26: 1803. doi:10.1038/s41591-020-01177-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01177-6</ArticleId><ArticleId IdType="pubmed">33288947</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet . Facing up to long COVID. Lancet 2020; 396: 1861. doi:10.1016/S0140-6736(20)32662-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32662-3</ArticleId><ArticleId IdType="pmc">PMC7834723</ArticleId><ArticleId IdType="pubmed">33308453</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics . Statistical bulletin: prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 1 April 2021. 2021. www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/1april2021
Date last accessed: 6 April 2021.</Citation></Reference><Reference><Citation>Buonsenso D, Munblit D, De Rose C, et al. . Preliminary evidence on long COVID in children. Acta Paediatr 2021; 110: 2208&#x2013;2211. doi:10.1111/apa.15870</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Say D, Crawford N, McNab S, et al. . Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. Lancet Child Adolesc Health 2021; 5: e22&#x2013;e23. doi:10.1016/S2352-4642(21)00124-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00124-3</ArticleId><ArticleId IdType="pmc">PMC8057863</ArticleId><ArticleId IdType="pubmed">33891880</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al. . 
Characterising long-term Covid-19: a rapid living systematic review. medRxiv
2020; preprint [10.1101/2020.12.08.20246025]. doi:2020.2012.2008.20246025</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.08.20246025</ArticleId></ArticleIdList></Reference><Reference><Citation>ISARIC Global COVID-19 Paediatric Follow-Up Working Group . ISARIC Global COVID-19 paediatric follow-up. 2021. https://isaric.org/research/covid-19-clinical-research-resources/paediatric-follow-up
Date last accessed: 24 April 2021.</Citation></Reference><Reference><Citation>Munblit D, Nekliudov NA, Bugaeva P, et al. . StopCOVID cohort: an observational study of 3,480 patients admitted to the Sechenov University Hospital Network in Moscow city for suspected COVID-19 infection. Clin Infect Dis 2021; 73: 1&#x2013;11. doi:10.1093/cid/ciaa1535</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1535</ArticleId><ArticleId IdType="pmc">PMC7665333</ArticleId><ArticleId IdType="pubmed">33035307</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Buonsenso D, DunnGalvin A, et al. . 
Consequences of COVID-19 infection for child health and wellbeing: protocol for a prospective, observational, longitudinal study in children. 2021. https://osf.io/d2wjn
Date last accessed: 24 April 2021.</Citation></Reference><Reference><Citation>Harris PA, Taylor R, Minor BL, et al. . The REDCap consortium: building an international community of software platform partners. J Biomed Inform 2019; 95: 103208. doi:10.1016/j.jbi.2019.103208</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103208</ArticleId><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, et al. . Research electronic data capture (REDCap) &#x2013; a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377&#x2013;381. doi:10.1016/j.jbi.2008.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. . 
Characterizing long COVID in an international cohort: 7&#x2005;months of symptoms and their impact. medRxiv
2020; preprint [10.1101/2020.12.24.20248802]. doi:2020.2012.2024.20248802</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.24.20248802</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court C, et al. . Management of post-acute Covid-19 in primary care. BMJ 2020; 370: m3026. doi:10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams K, Thomson D, Seto I, et al. . Standard 6: age groups for pediatric trials. Pediatrics 2012; 129: Suppl. 3, S153&#x2013;S160. doi:10.1542/peds.2012-0055I</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2012-0055I</ArticleId><ArticleId IdType="pubmed">22661762</ArticleId></ArticleIdList></Reference><Reference><Citation>Viner R, Gregorowski A, Wine C, et al. . Outpatient rehabilitative treatment of chronic fatigue syndrome (CFS/ME). Arch Dis Child 2004; 89: 615&#x2013;619. doi:10.1136/adc.2003.035154</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.2003.035154</ArticleId><ArticleId IdType="pmc">PMC1719984</ArticleId><ArticleId IdType="pubmed">15210489</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawley SA, Caporino NE, Birmaher B, et al. . Somatic complaints in anxious youth. Child Psychiatry Hum Dev 2014; 45: 398&#x2013;407. doi:10.1007/s10578-013-0410-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10578-013-0410-x</ArticleId><ArticleId IdType="pmc">PMC3989467</ArticleId><ArticleId IdType="pubmed">24129543</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, et al. . 
Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. medRxiv
2021; preprint [10.1101/2021.03.18.21253888]. doi:2021.2003.2018.21253888</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.18.21253888</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, et al. . 6-month neurological and psychiatric outcomes in 236&#x200a;379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 2021; 8: 416-427. doi:10.1016/S2215-0366(21)00084-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of long COVID. Nat Med 2021; 27: 626&#x2013;631. doi:10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, et al. . Post-Covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ 2021; 372: n693. doi:10.1136/bmj.n693</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin LB, Weinstock LB, Molderings GJ. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis 2020; 100: 327&#x2013;332. doi:10.1016/j.ijid.2020.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Khamsi R. Rogue antibodies could be driving severe COVID-19. Nature 2021; 590: 29&#x2013;31. doi:10.1038/d41586-021-00149-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-00149-1</ArticleId><ArticleId IdType="pubmed">33469204</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekliudov NA, Blyuss O, Cheung KY, et al. . Excessive media consumption about COVID-19 is associated with increased state anxiety: outcomes of a large online survey in Russia. J Med Internet Res 2020; 22: e20955. doi:10.2196/20955</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/20955</ArticleId><ArticleId IdType="pmc">PMC7490003</ArticleId><ArticleId IdType="pubmed">32788143</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>